MediCor was founded by Chairman of the Board Donald K. McGhan, the pioneer of the modern day breast implant industry. The Company acquires, develops, manufactures and markets products for medical specialties in aesthetic, plastic and reconstructive surgery and dermatology markets. Products include surgically implantable prostheses for aesthetic, plastic and reconstructive surgery and scar management products. Its products are sold worldwide to hospitals, surgery centers and physicians through various distributors and direct sales personnel. MediCor's strategy is to be the leading integrator of selected international medical device markets, technologies and corporations. To achieve this strategy, MediCor intends to build upon and expand its business lines, primarily in the aesthetic, plastic and reconstructive surgery and dermatology markets. MediCor intends to accomplish this growth through the expansion of existing product lines and offerings and through the acquisition of companies and other assets, including intellectual property rights or distribution rights.
View Top Employees from MediCor Ltd.Website | http://www.medicor.de |
Revenue | $5 million |
Employees | 1 (0 on RocketReach) |
Phone | (702) 731-2519 |
Industry | Medical Devices & Equipment, Manufacturing |
Competitors | Atc Technologies Inc, Bio Med Sciences, Inc., CENTER FOR PLASTIC & RECONSTRUCTIVE SURGERY, P.C., Implantech Associates, Inc., Ophthalmic Plastic Surgery |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
Looking for a particular MediCor Ltd. employee's phone or email?
The MediCor Ltd. annual revenue was $5 million in 2023.
MediCor Ltd. is based in Kerpen, Nordrhein-Westfalen.
The SIC codes for MediCor Ltd. are [38, 384].